IDMA to organise insights-exchange series ‘Vriddhi’ in Mumbai
Vriddhi S1 is being organised in Mumbai on 16th September, 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
IDMA
PharmaLytica Expo to aid in chalking out pharma industry’s $130 billion growth story by 2030
Amongst over 300 brands showcasing their latest developments and 30 conference speakers, the expo is anticipating more than 7,000…
Government wants to ease compliance burden on pharma industry: Mansukh Mandaviya
Stating that the industry plays an important role in nation-building and also in achieving self-reliance, the minister said that…
IPA Kerala and IDMA to conduct training programme for pharmacy graduates
The training course would consist of a series of well-conceived webinars by industrial experts from India and abroad, on various…
Centre to mandatorily revise ceiling prices of drugs every five years
The order is with regard to the Indian Drugs Manufacturers Association's (IDMA) views on notification No. S.O. 3249 (E), dated…
DoP takes measures to mandatorily revise ceiling prices of drugs every five years
Amends Para 18(i) of DPCO 2013 as per a notification issued on August 12, 2021
IDMA supports patent waiver for vaccines to ramp up production
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against…
There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi
A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
Industry welcomes PLI 2.0 Scheme, awaits implementation details
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more…
MoEF amendment brings APIs and intermediates under single category
This move provides flexibility to the industry to change the raw material mix/or product mix within the sanctioned pollution load